Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Liberty Capital who wrote (935)	11/18/1998 10:57:00 AM
From: Jeffrey S. Mitchell	Read Replies (1) \| Respond to of 1286

We hope that investors will see past the former management's hype* to the benefits and shareholder concern the new NBMX management team brings to the company.* Yes, clearly, you are correct that the former management team issued several recent press releases that were, as you say, more hype than substance. I look forward to see how the new management team does. But, how new is new? According to the opening post on this thread: Daniel Hoyng, president of National Boston stated: ''I back Bob [President and CEO of Fragrance Express Inc. (OTC BB:FGRX), Robert M. Bartlet] and the shareholders 100%. All appropriate avenues will be followed to conclusion. I look forward to a long lasting relationship with Bob and Fragrance Express.'' Does this mean former FGRX CEO, Robert Bartlet, is still active with the company? Is he a principal? Any other FGRX holdovers? - Jeff